Related Articles
Endosialin is expressed in high grade and advanced sarcomas: Evidence from clinical specimens and preclinical modeling
Endosialin: A novel malignant cell therapeutic target for neuroblastoma
Endosialin‑expressing bone sarcoma stem‑like cells are highly tumor‑initiating and invasive
Endosialin/CD248 may be a potential therapeutic target to prevent the invasion and metastasis in osteosarcoma
Human mesenchymal stem cells from bone marrow express tumor endothelial and stromal markers